Investigating receptor enzyme activity using time‐scale analysis

At early drug discovery, purified protein‐based assays are often used to characterise compound potency. In the context of dose response, it is often perceived that a time‐independent inhibitor is reversible and a time‐dependent inhibitor is irreversible. The legitimacy of this argument is investigated using a simple kinetics model, where it is revealed by model‐based analytical analysis and numerical studies that dose response of an irreversible inhibitor may appear time‐independent under certain parametric conditions. Hence, the observation of time‐independence cannot be used as sole evidence for identification of inhibitor reversibility. It has also been discussed how the synthesis and degradation of a target receptor affect drug inhibition in an in vitro cell‐based assay setting. These processes may also influence dose response of an irreversible inhibitor in such a way that it appears time‐independent under certain conditions. Furthermore, model‐based steady‐state analysis reveals the complexity nature of the drug–receptor process.